• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.

作者信息

Fosså S D, Ous S, Lien H H, Stenwig A E

机构信息

Department of Medical Oncology, Norwegian Radium Hospital, Oslo.

出版信息

J Urol. 1989 Mar;141(3):557-9. doi: 10.1016/s0022-5347(17)40892-5.

DOI:10.1016/s0022-5347(17)40892-5
PMID:2918591
Abstract

A total of 37 patients with initially advanced metastatic nonseminomatous testicular cancer underwent retroperitoneal lymph node dissection after cisplatin-based combination chemotherapy. Abdominal computerized tomography was negative at retroperitoneal lymphadenectomy (lymph nodes not exceeding 10 mm. in the transverse computerized tomography plane). Complete necrosis and fibrosis were found in 25 patients. In 11 patients the retroperitoneal lymphadenectomy specimen showed a mature teratoma. Residual vital malignant tumor was observed in 1 patient. Neither the initial size of the retroperitoneal mass nor the histological status of the primary tumor was predictive of the histological findings in the retroperitoneal lymphadenectomy specimen. The high frequency of mature teratoma raises the question whether omitting post-chemotherapy surgery is a safe routine policy in patients with negative computerized tomography, especially if long-term followup is not feasible. We recommend a post-chemotherapy retroperitoneal operation as routine treatment even in patients with negative computerized tomography.

摘要

相似文献

1
Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.
J Urol. 1989 Mar;141(3):557-9. doi: 10.1016/s0022-5347(17)40892-5.
2
Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.晚期非精原细胞瘤性睾丸癌患者化疗后肿瘤残留的组织学研究。
J Urol. 1989 Nov;142(5):1239-42. doi: 10.1016/s0022-5347(17)39044-4.
3
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.睾丸切除标本中的畸胎瘤及转移灶体积是化疗后非精原细胞瘤性睾丸癌腹膜后畸胎瘤的预测指标。
J Urol. 2002 Oct;168(4 Pt 1):1402-4. doi: 10.1016/S0022-5347(05)64458-8.
4
Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.非精原性生殖细胞肿瘤化疗后腹膜后畸胎瘤:是否存在预测因素?一项全国多中心研究的结果
J Surg Oncol. 2016 Dec;114(8):992-996. doi: 10.1002/jso.24464. Epub 2016 Nov 18.
5
Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?化疗后肿块冰冻切片分析显示坏死,这能否成为晚期睾丸癌患者进行有限腹膜后切除术的理由?
Br J Urol. 1997 Oct;80(4):653-7. doi: 10.1046/j.1464-410x.1997.00427.x.
6
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.原发性睾丸肿瘤中的畸胎瘤会降低初次化疗后腹膜后区域的完全缓解率。关于对伴有畸胎瘤成分的IIb期生殖细胞肿瘤进行原发性腹膜后淋巴结清扫术的理由。
Cancer. 1996 Aug 1;78(3):480-6. doi: 10.1002/(SICI)1097-0142(19960801)78:3<480::AID-CNCR15>3.0.CO;2-V.
7
[A case of teratoma of the testis with retroperitoneal lymph nodes involved with malignant teratoma after chemotherapy].1例睾丸畸胎瘤伴化疗后腹膜后淋巴结受累恶性畸胎瘤
Nihon Hinyokika Gakkai Zasshi. 1993 Dec;84(12):2162-5. doi: 10.5980/jpnjurol1989.84.2162.
8
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.转移性睾丸癌化疗后的残留肿块:腹膜后和肺部组织学关联的临床意义。睾丸癌组织学再分析(ReHiT)研究组
J Urol. 1997 Aug;158(2):474-8. doi: 10.1016/s0022-5347(01)64506-3.
9
Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.非精原细胞瘤性睾丸癌中残留腹膜后肿块组织学预测的有效性
J Clin Oncol. 1998 Jan;16(1):269-74. doi: 10.1200/JCO.1998.16.1.269.
10
Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
Cancer. 1986 Oct 1;58(7):1418-21. doi: 10.1002/1097-0142(19861001)58:7<1418::aid-cncr2820580706>3.0.co;2-t.

引用本文的文献

1
A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours.对接受非精原细胞瘤性生殖细胞肿瘤治疗的个体在化疗后腹膜后淋巴结清扫术中预测坏死或纤维化的临床病理特征的荟萃分析。
Front Oncol. 2022 Aug 17;12:931509. doi: 10.3389/fonc.2022.931509. eCollection 2022.
2
Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes.化疗后腹膜后淋巴结清扫术对睾丸癌结局的影响及实践模式。
Eur Urol Oncol. 2018 Aug;1(3):242-251. doi: 10.1016/j.euo.2018.04.005. Epub 2018 Jun 6.
3
Post chemotherapy retroperitoneal lymph node dissection in germ cell tumor: robotic way.
生殖细胞肿瘤化疗后腹膜后淋巴结清扫术:机器人手术方式
J Robot Surg. 2017 Jun;11(2):279-285. doi: 10.1007/s11701-016-0631-7. Epub 2016 Aug 8.
4
Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice.腹膜后淋巴结清扫术和切除术治疗睾丸癌:最佳实践的最新进展。
Ther Adv Urol. 2012 Aug;4(4):187-205. doi: 10.1177/1756287212443170.
5
Management of residual mass in nonseminomatous germ cell tumors following chemotherapy.化疗后非精原细胞瘤生殖细胞肿瘤残余肿瘤的处理。
Ther Adv Urol. 2011 Aug;3(4):163-71. doi: 10.1177/1756287211418721.
6
Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis.睾丸转移性非精原细胞性生殖细胞肿瘤患者化疗后残留肿块的管理。
Indian J Urol. 2010 Jan-Mar;26(1):98-101. doi: 10.4103/0970-1591.60448.
7
Canadian consensus guidelines for the management of testicular germ cell cancer.加拿大睾丸生殖细胞癌管理共识指南
Can Urol Assoc J. 2010 Apr;4(2):e19-38. doi: 10.5489/cuaj.815.
8
Late recurrences of germ cell malignancies: a population-based experience over three decades.生殖细胞恶性肿瘤的晚期复发:基于人群的三十年经验。
Br J Cancer. 2006 Mar 27;94(6):820-7. doi: 10.1038/sj.bjc.6603014.
9
Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience.
World J Urol. 2004 Apr;22(1):55-9. doi: 10.1007/s00345-003-0353-0.
10
Diagnosis and treatment of patients with testicular germ cell cancer.睾丸生殖细胞癌患者的诊断与治疗
Drugs. 1999 Aug;58(2):257-81. doi: 10.2165/00003495-199958020-00004.